Immunotherapy in Other Thoracic Malignancies and Uncommon Populations

Posted On 2021-07-07 11:36:52


In this special series of Translational Lung Cancer Research about “Immunotherapy in other thoracic malignancies and uncommon populations”, a group of renowned international specialists involved in the management of thoracic malignancies present a comprehensive and timely review of state-of-the-art of ICI in thoracic malignancies, discussing the lights and shadows of ICIs, either in under-represented patients with NSCLC in clinical trials, as well as the efficacy of ICIs in thoracic malignancies other than NSCLC.

Editorial on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Immunotherapy in other thoracic malignancies and uncommon populations
Jordi Remon, Benjamin Besse

Review Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?
Lizza E. L. Hendriks, Jordi Remon, Jessica Menis, Benjamin Besse

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
Francesco Passiglia, Valeria Cetoretta, Marco De Filippis, Valerio Napoli, Silvia Novello

Original Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
Giorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, Luc Friboulet, Francesco Facchinetti

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis
Francesco Facchinetti, Massimo Di Maio, Fabiana Perrone, Marcello Tiseo

Review Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Boris Duchemann, Jordi Remon, Marie Naigeon, Lydie Cassard, Jean Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Edouard Auclin, Aude Desnoyer, Benjamin Besse, Nathalie Chaput

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
Roberto Ferrara, Diego Signorelli, Claudia Proto, Arsela Prelaj, Marina Chiara Garassino, Giuseppe Lo Russo

Immunotherapy in small cell lung cancer: one step at a time: a narrative review
Daphne W. Dumoulin, Anne-Marie C. Dingemans, Joachim G. J. V. Aerts, Jordi Remon, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks

Immunotherapy in malignant pleural mesothelioma: a review of literature data
Jessica Menis, Giulia Pasello, Jordi Remon

Narrative review of immunotherapy in thymic malignancies
Jose Carlos Benitez, Benjamin Besse

Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review
Charles Naltet, Benjamin Besse

Disclosure:
The series “Immunotherapy in other thoracic malignancies and uncommon populations” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Jordi Remon and Benjamin Besse served as the unpaid Guest Editors for the series.